Ambeed.cn

首页 / / / / FTI-277 HCl

FTI-277 HCl {[allProObj[0].p_purity_real_show]}

货号:A136104 同义名: FTI-277 hydrochloride

FTI-277 HCl是一种法尼基转移酶 (FTase) 抑制剂和高效的 Ras CAAX 肽模拟剂,能拮抗 H- 和 K-Ras 致癌信号通路。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
FTI-277 HCl 化学结构 CAS号:180977-34-8
FTI-277 HCl 化学结构
CAS号:180977-34-8
FTI-277 HCl 3D分子结构
CAS号:180977-34-8
FTI-277 HCl 化学结构 CAS号:180977-34-8
FTI-277 HCl 3D分子结构 CAS号:180977-34-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

FTI-277 HCl 纯度/质量文件 产品仅供科研

货号:A136104 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Autophagy 其他靶点 纯度
SBI-0206965 +++

ULK1, IC50: 108 nM

ULK2, IC50: 711 nM

95%
Hydroxychloroquine sulfate 99%
Valproic acid sodium HDAC 97%
PFK-015 ++

PFKFB3, IC50: 207 nM

99%+
MRT68921 HCl ++++

ULK1, IC50: 2.9 nM

ULK2, IC50: 1.1 nM

99%+
ROC-325 99%+
Autophinib +++

Autophagy, IC50: 40 nM

99%
Lys05 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 Transferase 其他靶点 纯度
Tipifarnib +++

FTase, IC50: 0.6 nM

99%+
Tolcapone +

COMT, Ki: 30 nM

99%+
Lonafarnib +++

H-ras, IC50: 1.9 nM

K-ras-4B, IC50: 2.8 nM

99%+
(E)-Daporinad ++++

NMPRTase, Ki: 0.4 nM

99%+
FTI-277 HCl ++++

FTase, IC50: 500 pM

98%
A 922500 ++

human DGAT-1, IC50: 7 nM

mouse DGAT-1, IC50: 24 nM

98%
Lomeguatrib ++

O6-alkylguanine-DNA-alkyltransferas, IC50: 5 nM

99%+
PF-04620110 +

DGAT1, IC50: 19 nM

99%
LB42708 +++

FTase (K-Ras), IC50: 0.8 nM

FTase (N-ras), IC50: 1.2 nM

98%
GGTI298 Trifluoroacetate 98%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

FTI-277 HCl 生物活性

靶点
  • Transferase

    FTase, IC50:500 pM

描述 FTI-277, when used at 20 micrometers for 48 hours before irradiation, notably decreases the survival of radioresistant HeLa 3A cells expressing a 24-kDa isoform but does not affect the survival of control HeLa PINA cells. This radiosensitizing effect of FTI-277 is accompanied by an increase in postmitotic cell death in HeLa 3A cells and a decrease in G(2)/M phase arrest in both cell lines[1]. GGTI-298 and FTI-277 treatments hinder migration and invasion of PC-3 cells in both time- and dose-dependent manners[3].
体内研究

FTI-277 therapy prevents the rise in PTP-1B and PTEN protein levels seen in burned mice when compared to the vehicle control. Conversely, FTI-277 doesn't significantly change the expression levels of PTP-1B and PTEN in sham-burned mice[2].

体外研究

FTI-277, when used at 20 micrometers for 48 hours before irradiation, notably decreases the survival of radioresistant HeLa 3A cells expressing a 24-kDa isoform but does not affect the survival of control HeLa PINA cells. This radiosensitizing effect of FTI-277 is accompanied by an increase in postmitotic cell death in HeLa 3A cells and a decrease in G(2)/M phase arrest in both cell lines[1].

GGTI-298 and FTI-277 treatments hinder migration and invasion of PC-3 cells in both time- and dose-dependent manners[3].

FTI-277 HCl 细胞实验

Cell Line
Concentration Treated Time Description References
Human mesenchymal stem cells (MSC) 5 µM and 10 µM 1 week and 3 weeks FTI-277 significantly affected osteoblast differentiation (approx. -50±10%) and function (approx. -60±15%), with a higher inhibitory effect at 10 μM. Alendronate reversed the inhibitory effect of FTI-277. Br J Pharmacol. 2011 Mar;162(5):1109-18.
Human mesenchymal stem cells (MSC) 5 µM and 10 µM 2 weeks Assessed the effect of FTI-277 on HDJ-2 and prelamin A, finding that FTI-277 inhibited farnesylation of both proteins, with a dose-dependent increase in unfarnesylated protein levels. Br J Pharmacol. 2011 Mar;162(5):1109-18.
HELN cells 10 µM 24 hours In HELN cells, FTI-277 and GGTI-298 stimulated basal transcriptional activity by 3.6-fold and 2.4-fold, respectively, in the absence of E2. In the presence of E2, FTI-277 and GGTI-298 further enhanced transcriptional activity by an additional 2.2-fold and 1.6-fold, respectively. Breast Cancer Res. 2005;7(1):R60-70.
MCF-7 cells 10 µM 24 hours FTI-277 significantly enhanced E2-induced transcriptional activity. In the absence of E2, FTI-277 and GGTI-298 stimulated basal transcriptional activity by 8.4-fold and 3.9-fold, respectively. In the presence of E2, FTI-277 and GGTI-298 further enhanced transcriptional activity by an additional 4.1-fold and 2.5-fold, respectively. Breast Cancer Res. 2005;7(1):R60-70.
ESC-derived VEGFR2+ cells 3 µM 4 days Under low-density culture conditions, FTI-277 significantly reduced PECAM1+ colony numbers and increased αSMA+ colonies, indicating specific inhibition of endothelial differentiation. J Cell Biol. 2008 Apr 7;181(1):131-41.
MCF7 breast cancer cells 5 µM 48 hours Combined use of FTI-277 and IPA3 did not significantly inhibit cell proliferation Mol Cancer. 2013 Aug 6;12(1):88.
A549 lung cancer cells 5 µM 48 hours Combined use of FTI-277 and IPA3 significantly inhibited cell proliferation Mol Cancer. 2013 Aug 6;12(1):88.
HT29 colon cancer cells 5 µM 48 hours Combined use of FTI-277 and IPA3 significantly inhibited cell proliferation Mol Cancer. 2013 Aug 6;12(1):88.
A375MM melanoma cells 5 µM or 15 µM 48 hours FTI-277 treatment did not affect PAK protein levels but increased nuclear PhoPAK clusters Mol Cancer. 2013 Aug 6;12(1):88.
HeLa cells 5 µM or 15 µM 48 hours After 48 h of FTI-277 treatment, PAK and PhoPAK signals significantly increased Mol Cancer. 2013 Aug 6;12(1):88.
SH-SY5Y cells 100 nM 48 hours Reduced the abundance of membrane-associated UCH-L1 (UCH-L1M), decreased α-synuclein levels, and increased cell viability Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4635-40.
MCF-7 cells 10 µM 48 hours To evaluate the effect of FTI-277 on cell proliferation, results showed that FTI-277 treatment significantly inhibited the proliferation of MCF-7 cells. Cancer Lett. 2010 Jan 28;287(2):172-81.
4T1 cells 10 µM 48 hours To evaluate the effect of FTI-277 on cell proliferation, results showed that FTI-277 treatment significantly inhibited the proliferation of 4T1 cells. Cancer Lett. 2010 Jan 28;287(2):172-81.
67NR cells 10 µM 48 hours To evaluate the effect of FTI-277 on cell proliferation, results showed that FTI-277 treatment significantly inhibited the proliferation of 67NR cells. Cancer Lett. 2010 Jan 28;287(2):172-81.
ESC-derived VEGFR2+ cells 1 µM 48 hours FTI-277 added within 3 hours post-VEGF-A stimulation suppressed endothelial differentiation, but no effect when added after 6 hours, demonstrating time-dependent inhibition. J Cell Biol. 2008 Apr 7;181(1):131-41.
COS-7 cells 100 nM Decreased the amount of transfected WT UCH-L1M Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4635-40.
B16F10 melanoma cells 10 or 20 µM 48 hours FTI-277 did not enhance membrane FasL expression Neoplasia. 2007 Dec;9(12):1078-90.
Human bronchial mesenchymal fibroblasts 10 µM 48 hours To investigate the effect of FTI-277 on TGFβ1-induced fibronectin expression; results showed no significant inhibition of fibronectin accumulation Respir Res. 2011 Aug 24;12(1):113.
MCF-7 cells 5.9 nM 5 days To evaluate the inhibitory effects of FTI-277 in combination with different anti-estrogens on MCF-7 cell proliferation. Results showed that FTI-277 combined with Tam had an additive effect, while combinations with ICI182,780 or PBPE exhibited synergistic effects. Breast Cancer Res. 2005;7(6):R1159-67.
CNE1 cells 1 µM 72 hours FTI-277 in combination with cisplatin slightly enhanced cytotoxicity in NPC cells with medium CENP-F expression Mol Cancer. 2010 Sep 9;9:237.
HONE1 cells 1 µM 72 hours FTI-277 in combination with cisplatin significantly enhanced cytotoxicity in NPC cells with high CENP-F expression Mol Cancer. 2010 Sep 9;9:237.
Murine bone marrow-derived mast cells 5 µM 72 hours Inhibition of Ras isoprenylation significantly reduces mast cell degranulation, cytokine production, and migration 2020 Oct 28;11:585070. doi: 10.3389/fimmu.2020.585070.
3T3-L1 cells 20 µM(first 24 h), then 2.5 µM (next 7 days) 8 days To investigate the effect of FTI-277 on adipogenesis in 3T3-L1 cells. Results showed that FTI-277 increased the number of mature adipocytes, but when combined with non-farnesylated prelamin A accumulation, it reduced the expression of adipogenic genes. Int J Mol Sci. 2024 Jan 20;25(2):1282.
CHO-K1 cells 1 µM 8 hours An 8 h treatment with 1μM FTI-277 led to an increase in p27 expression in cells that were selected before analysis for H-2Kk expression on magnetic beads conjugated to a monoclonal antibody against H-2Kk. EMBO Rep. 2004 Jul;5(7):721-7.
HeLa cells 1 µM 8 hours Addition of FTI-277 resulted in a 10- to 20-fold increase in LucF translation with a reporter containing the R17-binding site. EMBO Rep. 2004 Jul;5(7):721-7.
SK-Hep1 cells 1 µM 8 hours FTI-277 prevents the membrane association of the CAAX motif and thus increases the cytoplasmic levels of the eIF4G fusion protein, which is then capable of inducing translation of the second cistron of a bicistronic messenger RNA containing an R17-binding site in its intercistronic space. EMBO Rep. 2004 Jul;5(7):721-7.

FTI-277 HCl 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice E6.75 whole-embryo culture model In vitro culture medium 10 μM Single dose, cultured for 3 days FTI-277 treatment diminished PECAM1+ vessels in yolk sacs, with decreased PECAM1 and VE-cadherin mRNA levels but unchanged αSMA expression, suggesting suppression of vascular development. J Cell Biol. 2008 Apr 7;181(1):131-41.
Mice Dopaminergic neurons in midbrain mixed primary cultures Added to culture medium 100 nM Single treatment, duration not specified Reduced α-synuclein toxicity Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4635-40.
Mice HBV transgenic mice Intraperitoneal injection 50 mg/kg/day Once daily for 7 days FTI-277 and FTI-2153 were both highly effective at clearing HDV viremia J Clin Invest. 2003 Aug;112(3):407-14

FTI-277 HCl 参考文献

[1]Cohen-Jonathan E, et al. The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS. Radiat Res. 1999 Oct;152(4):404-11.

[2]Nakazawa H, et al. Role of protein farnesylation in burn-induced metabolic derangements and insulin resistance in mouse skeletal muscle. PLoS One. 2015 Jan 16;10(1):e0116633.

[3]Virtanen SS, et al. Inhibition of GGTase-I and FTase disrupts cytoskeletal organization of human PC-3 prostate cancer cells. Cell Biol Int. 2010 Aug;34(8):815-26.

FTI-277 HCl 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.07mL

0.41mL

0.21mL

10.33mL

2.07mL

1.03mL

20.66mL

4.13mL

2.07mL

FTI-277 HCl 技术信息

CAS号180977-34-8
分子式C22H30ClN3O3S2
分子量 484.07
SMILES Code CSCC[C@@H](C(OC)=O)NC(C1=CC=C(NC[C@@H](N)CS)C=C1C2=CC=CC=C2)=O.[H]Cl
MDL No. MFCD28385886
别名 FTI-277 hydrochloride
运输蓝冰
InChI Key PIAFFJUUNXEDEW-PXPMWPIZSA-N
Pubchem ID 88309922
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, 2-8°C

溶解方案

DMSO: 105 mg/mL(216.91 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 100 mg/mL(206.58 mM),配合低频超声助溶

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。